Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch on Radcliffe Cardiology:

In this short and clinical practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) talks about selected ACC.22 late-breaking clinical trials from an interventional perspective.

Trials covered in detail include:

00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

01:46: GHATI: Improving STEMI Management Internationally: Two-year Report of 4,015 Patients Enrolled in the American College of Cardiology - Global Heart Attack Treatment Initiative

02:37: Insights From the Corevalve US Pivotal and SURTAVI Trials: Five-year Incidence, Timing and Predictors of Hemodynamic Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses

03:30: The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

04:34: A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement

Recorded on-site at ACC.22, Washington DC.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "ACC 22: 5 Trials That Will Change Your Practice with Dr Mirvat Alasnag" передвинте ползунок вправо